報價延遲最少15分鐘:2026/04/17 23:43 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.11 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.33/-1.20
|
|
企業價值
199.64M
|
| 資產負債 |
|
每股賬面淨值
2.89
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
7.15M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products. |
